Klotho’s role in some patients with Alzheimer’s disease revealed?

April 24, 2020 – The klotho gene is named after the fanciful Greek goddess of destiny Clotho who turns the string of life known to be related with longer life and improved cognizance. In modern biology, allelic variants of the klotho gene in fact have been associated with long life span. Klotho seems also related to a defensive capacity against psychological debilitations and Alzheimer’s disease (AD) in people conveying variants of the APOE4 gene that predispose individuals to a higher risk for the development of AD, a recent study from Stanford University, published online April 13 in JAMA. Neurology, has found.

Individuals who are heterozygous (i.e., they are carrying one copy out of two) for a particular klotho allelic variant known as klotho-VS, estimated to be about 25% of the population, produce increased serum levels of the klotho protein, which is associated with protective effects on healthy aging and longevity compared with those with no or two (i.e., being homozygous for this variant) klotho-VS alleles. Previous observational studies indicated that patients carrying certain forms of the APOE4 gene were at heightened genetic susceptibility for development of dementia along with heightened susceptibility  to the detrimental effects of various lifestyle-related risk factors, mostly because of varying degrees of amyloid bild-up in the brain (i.e., cerebrum). As recently as 2019 it was found that people carrying the APOE4 gene who had a heterozygous klotho-VS status had less amyloid in the cerebrum.

These observations led to the questions if patients with a heterozygous klotho-VS status could be protected from developing neurodegenerative diseases, such as AD, for example, and whether patients who are known to carr the APOE4 gene could be candidates for remedy of their future danger of development of AD by boosting pathways identified to dependent of klotho.

In an attempt to answer at least some of the aspects of these questions, the authors of the present study investigated 25 datasets of people with hereditary data accessible on the APOE4 and klotho genotypes. Thus, the researchers analyzed these independent datasets from case-control, family-based, and longitudinal Alzheimer’s cohorts. The risk of developing mild cognitive impairment or Alzheimer’s was evaluated through competing risks regression under a case-control design. Associations with beta-amyloid, measured from cerebrospinal fluid (CSF) or brain positron emission tomography (PET), were evaluated using linear regression and mixed-effects modeling.

Participants were men and women aged 60 years and older who were non-Hispanic and of Northwestern European ancestry and had been diagnosed as being cognitively normal or having mild cognitive impairment or Alzheimer’s. The sample included 20,928 participants in case-control studies, 3008 in conversion studies, 556 in beta-amyloid CSF regression analyses, and 251 in PET regression analyses. Results showed that individuals who were heterozygous for the klotho-VS gene had a reduced risk for Alzheimer’s in those carrying APOE4 (odds ratio [OR], 0.75; 95% confidence interval [CI], 0.67 – 0.84) among the whole population aged over 60 years. This was more prominent in those aged 60 to 80 years (OR, 0.69; 95% CI, 0.61 – 0.79). In addition, control participants carrying APOE4 with klotho-VS heterozygosity were at reduced risk of converting to mild cognitive impairment or Alzheimer’s (hazard ratio, 0.64; 95% CI, 0.44 – 0.94). Further, in control participants who carried APOE4 and were aged 60 to 80 years, klotho-VS heterozygosity was associated with higher beta-amyloid in CSF (correlating to lower levels in the brain) and lower beta-amyloid on PET scans.

In contrast, however, klotho-VS status had no association with outcome in individuals who did not carry APOE4 .

The outcomes of this research are intriguing and propose new pathways for Alzheimer’s exploration. For the moment, these outcomes will help with guiding individuals who are known to carry  the APOE4 gene in therapeutic approaches. The research also opens new questions as to why a few people with the APOE4 gene never develop AD and whether heterozygosity in klotho-VS status could be the crucial determent in these clinical phenotype.

See a short sequence on some molecular events around amyloid in AD-affected brains which may be influenced by klotho-VS status:

Print Friendly, PDF & Email

 

 

Tags: , , , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion

Comment

@peepso_user_32129(Geetha) It seems to be an interesting post. My father is suffering from Alzheimer’s disease for nearly ten years. I came to know about popular neurologist in Chennai through the site https://www.drgbalamurali.com/. The study mentioned above offers some interesting results.
preview thumbnail
Dr.G.Balamurali, Senior Spine Consultant & Best Neurology Specialist in Chennai. Internationally Trained Neuro Specialist With 15 Years Experience In UK.
6 months ago 6 months ago

thasso: conditions

thasso: newest tweets

thasso: recent comments

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • New COVID-19 related genes—helpful and harmful—found in massive screen October 26, 2020
    Researchers at Yale University and the Broad Institute of MIT and Harvard screened hundreds of millions of cells exposed to the COVID-19 and MERS viruses and identified dozens of genes that both enable the viruses to replicate in cells and also those that seem to slam the door on the virus.
  • Genetic predisposition to increased weight is protective for breast and prostate cancer October 26, 2020
    Although a recent campaign by Cancer Research UK emphasized obesity as a risk factor for cancer on par with smoking, the scientific literature on the relationship between increased weight and cancer risk is not so clear. In a new analysis, researchers from Brunel University London found that increasing weight is causally protective for breast and […]
  • Insights into the genetic architecture of penicillin allergy October 26, 2020
    Researchers announce the first robust evidence for the role of the major histocompatibility complex gene HLA-B in penicillin allergy. To identify genetic risk factors for penicillin allergy, the international team of researchers harnessed self-reported data and the electronic health records of more than 600,000 people, as well as replicating their findings in two independent research […]
  • Breast cancer risk and disease-causing mutations in women over age 65 October 26, 2020
    Women with the onset of breast cancer over age 65 often do not qualify for genetic testing, yet little is known about the frequency of disease-causing mutations in breast cancer predisposition genes in this population. In a new study, researchers investigated the prevalence of disease-causing variants in established breast cancer predisposition genes and estimated the […]
  • Cell-free DNA provides a dynamic window into health October 26, 2020
    Short fragments of cell-free DNA (cfDNA) that circulate in blood, urine, and other biofluids can offer an information-rich window into human physiology and disease. By looking at the methylation markers of cfDNA, researchers can identify the tissue from which the DNA came. A new study used this method to monitor infectious and immune-related diseases, including […]
  • 3D printing the first ever biomimetic tongue surface October 26, 2020
    Scientists have created synthetic soft surfaces with tongue-like textures for the first time using 3D printing, opening new possibilities for testing oral processing properties of food, nutritional technologies, pharmaceutics and dry mouth therapies.
  • Surprised researchers: Number of leopards in northern China on the rise October 26, 2020
    Most of the world's leopards are endangered and generally, the number of these shy and stunning cats is decreasing. However, according to a recent study by a researcher from University of Copenhagen and colleagues from China, leopard populations in northern China are on the mend. Discover why below.
  • Powering the future: new insights into how alkali-metal doped flexible solar cells work October 26, 2020
    A group of scientists from Korea has discovered that the amount of alkali metal introduced into crystals of flexible thin-film solar cells influences the path that charge carriers take to traverse between electrodes, thereby affecting the light-to-electricity conversion efficiency of the solar cell. Given the immense application potential that such solar cells have today, this […]
  • Scientists establish NanDeSyn Database to support international cooperation on industrial microalgae October 26, 2020
    To promote resource sharing and research cooperation for the synthetic biology and molecular breeding of industrial oil-producing microalgae, an international team led by Single-Cell Center (SCC), Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences (CAS), has released the "NanDeSyn Database" (http://www.nandesyn.org).
  • A heart-breast cancer-on-a-chip monitoring system October 26, 2020
    Dual-organ system enables the measurement of cardiac toxicity arising from breast cancer chemotherapy. A collaborative team, which includes a group from the Terasaki Institute for Biomedical Innovation, has developed an organs-on-a-chip system that more widely examines the responses of breast cancer and heart tissues to therapeutic breast cancer drugs.
Top